Fluorescent In Situ Hybridization for Human Epidermal Growth Factor Receptor 2 Assessment in Breast Cancer: Is It Applicable As a Primary Test?

被引：10

作者：

Arena, Vincenzo ^{[1
]}

Pennacchia, Ilaria ^{[1
]}

Carbone, Arnaldo ^{[1
]}

Capelli, Arnaldo ^{[1
]}

机构：

[1] Univ Cattolica Sacro Cuore, Inst Pathol, I-00168 Rome, Italy

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 19期

关键词：

D O I：

10.1200/JCO.2009.23.2249

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：E8 / E8

页数：1

共 3 条

[1]

Standardization of HER2 testing:: results of an international proficiency-testing ring study [J].

Dowsett, Mitch ;

Hanna, Wedad M. ;

Kockx, Mark ;

Penault-Llorca, Frederique ;

Rueschoff, Josef ;

Gutjahr, Thorsten ;

Habben, Kai ;

van de Vijver, Marc J. .

MODERN PATHOLOGY, 2007, 20 (05) :584-591

[2]

Fluorescence in situ hybridization on formalin-fixed and paraffin-embedded tissue [J].

Petersen, BL ;

Sorensen, MC ;

Pedersen, S ;

Rasmussen, M .

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2004, 12 (03) :259-265

[3]

Guidelines for Human Epidermal Growth Factor Receptor 2 Testing: Biologic and Methodologic Considerations [J].

Sauter, Guido ;

Lee, James ;

Bartlett, John M. S. ;

Slamon, Dennis J. ;

Press, Michael F. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (08) :1323-1333

← 1 →